Get started
AMGENAMGENAMGEN

AMGEN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

1AMGN chart


Full chart

Key facts today

Shares of Amgen rose 2.5% after Novo Nordisk's CagriSema experimental obesity therapy fell short of expectations, creating a favorable environment for Amgen's obesity drug developments.
Analyze the impactAnalyze the impact

1AMGN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪136.65 B‬ EUR
Dividend yield (indicated)
3.61%
Price to earnings Ratio (TTM)
33.05
Basic EPS (TTM)
7.10 EUR
Net income (FY)
‪6.09 B‬ EUR
Revenue (FY)
‪25.38 B‬ EUR
Shares float
‪536.25 M‬
Beta (1Y)
0.61

Employees


Employees (FY)
‪26.7 K‬
Change (1Y)
‪+1.5 K‬ +5.95%
Revenue / Employee (1Y)
‪950.46 K‬ EUR
Net income / Employee (1Y)
‪227.93 K‬ EUR

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
FIGI
BBG00J7BK058
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1AMGN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

1AMGN highest yielding bonds


AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053
Yield to maturity
7.15%
Maturity date
Sep 1, 2053
AMGN5235280
Amgen Inc. 3.0% 15-JAN-2052
Yield to maturity
6.85%
Maturity date
Jan 15, 2052
US31162CS7
AMGEN 20/50
Yield to maturity
6.73%
Maturity date
Feb 21, 2050
AMGN5235282
Amgen Inc. 2.8% 15-AUG-2041
Yield to maturity
6.62%
Maturity date
Aug 15, 2041
US31162CR9
AMGEN 20/40
Yield to maturity
6.50%
Maturity date
Feb 21, 2040
AMGD
AMGEN 22/52
Yield to maturity
6.48%
Maturity date
Feb 22, 2052
US31162BP4
AMGEN 12/43
Yield to maturity
6.46%
Maturity date
May 15, 2043
US31162DG2
AMGEN 22/62
Yield to maturity
6.43%
Maturity date
Feb 22, 2062
US31162BZ2
AMGEN 15/45
Yield to maturity
6.30%
Maturity date
May 1, 2045
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
6.25%
Maturity date
Jun 15, 2048
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
6.23%
Maturity date
Jun 15, 2051

Explore more bonds 

Sparks


Curated watchlists where 1AMGN is featured.

See all sparks 

Frequently Asked Questions


The current price of 1AMGN is 255.85 EUR — it has increased by 2.65% in the past 24 hours. Watch AMGEN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange AMGEN stocks are traded under the ticker 1AMGN.
1AMGN stock has fallen by −1.24% compared to the previous week, the month change is a −3.87% fall, over the last year AMGEN has showed a 0.81% increase.
We've gathered analysts' opinions on AMGEN future price: according to them, 1AMGN price has a max estimate of 390.91 EUR and a min estimate of 188.21 EUR. Watch 1AMGN chart and read a more detailed AMGEN stock forecast: see what analysts think of AMGEN and suggest that you do with its stocks.
1AMGN reached its all-time high on Aug 1, 2024 with the price of 337.65 EUR, and its all-time low was 138.00 EUR and was reached on Mar 29, 2018. View more price dynamics on 1AMGN chart.
See other stocks reaching their highest and lowest prices.
1AMGN stock is 6.54% volatile and has beta coefficient of 0.61. Track AMGEN stock price on the chart and check out the list of the most volatile stocks — is AMGEN there?
Today AMGEN has the market capitalization of ‪136.65 B‬, it has decreased by −2.70% over the last week.
Yes, you can track AMGEN financials in yearly and quarterly reports right on TradingView.
AMGEN is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
1AMGN earnings for the last quarter are 5.01 EUR per share, whereas the estimation was 4.74 EUR resulting in a 5.79% surprise. The estimated earnings for the next quarter are 4.87 EUR per share. See more details about AMGEN earnings.
AMGEN revenue for the last quarter amounts to ‪7.64 B‬ EUR, despite the estimated figure of ‪7.63 B‬ EUR. In the next quarter, revenue is expected to reach ‪8.55 B‬ EUR.
1AMGN net income for the last quarter is ‪2.54 B‬ EUR, while the quarter before that showed ‪696.47 M‬ EUR of net income which accounts for 264.95% change. Track more AMGEN financial stats to get the full picture.
Yes, 1AMGN dividends are paid quarterly. The last dividend per share was 2.12 EUR. As of today, Dividend Yield (TTM)% is 3.42%. Tracking AMGEN dividends might help you take more informed decisions.
AMGEN dividend yield was 2.96% in 2023, and payout ratio reached 68.24%. The year before the numbers were 2.95% and 64.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪26.70 K‬ employees. See our rating of the largest employees — is AMGEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMGEN EBITDA is ‪10.85 B‬ EUR, and current EBITDA margin is 44.11%. See more stats in AMGEN financial statements.
Like other stocks, 1AMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMGEN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMGEN technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMGEN stock shows the neutral signal. See more of AMGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.